SELLAS Life Sciences Group, Inc. (SLS)
About SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $0
- Net income
- -$26.9M
- Total assets
- $78.3M
- Market cap
- $1.6B
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Cost of revenue
- $0
- Operating income
- -$28.3M
- Income tax
- $0
- Net income
- -$26.9M
- EPS (basic)
- $-0.25
- EPS (diluted)
- $-0.25
Balance sheet
- Total assets
- $78.3M
- Current assets
- $75.2M
- Total liabilities
- $7.5M
- Current liabilities
- $7.0M
- Shareholders’ equity
- $70.9M
Cash flow
- Operating cash flow
- -$28.4M
- Investing cash flow
- -$57.9M
- Financing cash flow
- $86.3M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.6B
- EPS (diluted)
- $-0.25
- Dividend yield
- 8.49%
- Shares outstanding
- 143.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 12, 2008
SELLAS Life Sciences Group, Inc. (SLS) Stock Price
- Reported a net loss of $26.9M in FY2023.
- Trading 27% below its 52-week high.
- Pays a dividend yielding about 8.49% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SELLAS Life Sciences Group, Inc..
Write a review
News about SELLAS Life Sciences Group, Inc.
News & sentiment via Polygon.io
SELLAS Life Sciences Group, Inc.: frequently asked questions
Is SELLAS Life Sciences Group, Inc. an American company?
SELLAS Life Sciences Group, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is SELLAS Life Sciences Group, Inc. headquartered?
SELLAS Life Sciences Group, Inc. is headquartered in New York, New York, United States.
Is SELLAS Life Sciences Group, Inc. publicly traded?
Yes — SELLAS Life Sciences Group, Inc. is a publicly traded company. Its stock trades under the ticker symbol SLS on the NASDAQ.
What does SELLAS Life Sciences Group, Inc. do?
SELLAS Life Sciences Group, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
